血清肿瘤标记物,Serum tumor marker
1)Serum tumor marker血清肿瘤标记物
1.Purpose: To evaluate the combined application CT and serum tumor markers in diagnosis and staging ovarian carcinoma.目的:评价CT和血清肿瘤标记物联合检查在卵巢癌诊断与分期中的价值。
2.Objective:To assess the value of combined testing of serum tumor markers in the diagnosis of gallbladder carcinoma.目的 :观察胆囊癌患者血清肿瘤标记物的表达 ,分析血清肿瘤标记物联合检测在胆囊癌诊断中的作用。
3.Objective Carbohydrate antigen 50 (CA50) and 242 (CA242), recently recognized as serum tumor markers, are studied for their value in the diagnosis of the colorectal carcinoma.结论CA50和CA242的血清水平在结直肠癌中比结直肠良性疾病中为高,在结直肠癌的晚期比早期为高,对结直肠癌的临床诊断具有一定价值,可和其他血清肿瘤标记物联合检测,互相弥补以提高检出率;也可通过动态观察其血清水平,推测患者病情的进展。
英文短句/例句
1.Clinical Significance of Combined Detection of Serum Tumor Markers in Lung Cancer Patients肺癌血清肿瘤标记物的联合检测及其临床意义
2.Identification of serum tumormarkers for diagnosing stage Ⅰ lung squamous cell carcinoma by MALDI-TOF mass spectrometryMALDI-TOF质谱技术筛选Ⅰ期肺鳞癌血清肿瘤标记物
3.The Prognosis Factors on Local Resection of Uveal Melanoma and the Serum Markers of the Tumor;葡萄膜黑色素瘤局部切除预后影响因素及血清肿瘤标记物探讨
4.Clinical Significance in Diagnosing Lung Cancer with the Combined Determination of Serum Tumor Markers;血清肿瘤标记物联合检测在肺癌诊断中的临床意义
5.Experimental Research of Screening Biomarkers in the Sera of PLC with Phage Random Peptide Library噬菌体随机肽库筛选肝癌患者血清肿瘤标记物的实验研究
6.Screening and Identification of Gastric Carcinoma Associated Antigens and Serum Biomarkers by Immunoproteomics;利用免疫蛋白组学技术筛选和鉴定胃癌肿瘤相关抗原及血清肿瘤标记物
7.Detection of serum protein biomarkers by surface enhancedlaser desorption ionization time of flight mass spectrometry(SELDI-TOF-MS) in patients with non-small cell lung cancerSELDI-TOF-MS技术筛选NSCLC血清肿瘤标志物
8.Clinical Significance of Combined Detection of Serum Levels of Multiterm Tumor Markers in Patients with Upper Gastrointestinal Cancer上消化道恶性肿瘤患者血清多项肿瘤标志物联合检测的临床意义
9.The Study on Combined Detection of P53 Protein and Tumor Markers in Serum for Patients with Digestive Cancer消化系统肿瘤患者血清P53蛋白与肿瘤标志物联合检测的临床意义
10.Three Serum Tumor Markers of Diagnostic Value of Joint Detection Analysis三种血清肿瘤标志物联合检测对恶性肿瘤的诊断价值
11.Value of Detection of P53 Protein and Tumor Markers in Serum for Auxiliary Diagnosis of the Distant Metastasis of Digestive Malignant Neoplasm血清P53蛋白与肿瘤标志物检测辅助诊断消化系统肿瘤转移的价值
12.The Clinical Study of Five Serum Tumor Markers in Lung Carcinoma;五种血清肿瘤标志物在肺癌中的临床应用研究
13.Research on Suspension Array Reagents Used for Detection of Human Serum Tumor Markers;人血清肿瘤标志物液相芯片检测系统的研制
14.The Research of Serum Tumor Biomarkers for Pancreatic Carcinoma by Comparative Proteomics胰腺癌血清肿瘤标志物的蛋白质组学研究
15.Advances on Serum Tumor Markers of Early Diagnosis of Ovarian Cancer卵巢癌早期诊断的血清肿瘤标志物研究进展
16.CIinicaI significance of 5 serum markers in diagnosis of breast cancer肿瘤血清标志物在乳腺癌诊断中的意义
parative study of diagnostic value of serum tumor markers for lung cancer血清肿瘤标志物对肺癌诊断价值的比较研究
18.Advances in research of gastric and colorectal cancer-associated serum tumor markers胃癌、结直肠癌相关血清肿瘤标志物研究进展
相关短句/例句
Serum tumor markers血清肿瘤标记物
3)serum tumor marker血清肿瘤标志物
1.Objective To study the clinical value ofserum tumor marker determination and whole body bone scan for diagnosis of bone metastases from breast cancer.目的:探讨联检血清肿瘤标志物和放射性核素骨显像对诊断乳腺癌骨转移的临床价值。
2.Methods Serum tumor markers (CA153、CA125、CEA、FER ) were assayed with CLIA and whole body bone scan were investigated with SPECT on 174 breast cancer patients.目的探讨血清肿瘤标志物预测乳腺癌骨转移的临床价值。
4)Serum tumor markers血清肿瘤标志物
1.Significance of measurement of serum tumor markers in differential diagnosis of mass lesion on pancreatic head血清肿瘤标志物在胰头部肿块鉴别诊断中的作用
5)Tumor marker肿瘤标记物
1.Clinical evaluation of five tumor markers in peripheral blood from patients with gastric cancer;胃癌患者外周血中五种肿瘤标记物测定的临床意义
2.Clinical utility of serum tumor markers in mature cystic teratoma of the ovary and its malignant transformation;血清肿瘤标记物测定在卵巢成熟畸胎瘤及其恶变者的临床应用
3.The determination and clinical evaluation of tumor markers in the patients with ovarian tumor;卵巢癌的肿瘤标记物测定与临床评价
6)tumor biomarkers肿瘤标记物
延伸阅读
肿瘤标记物肿瘤标记物是指肿瘤组织产生的可以反映肿瘤自身存在的化学物质，又称肿瘤标志物。这类物质可以是大分子的蛋白质(包括肽类激素和酶)，也可以是小分子的脂类和氨基酸衍生物。理想的肿瘤标志物应该是肿瘤组织所特有而不存在于正常组织。然而迄今为止，还未找到这种正常组织中绝对不存在的肿瘤特异成分，故肿瘤标志物一般是指肿瘤组织和相应的正常组织相比，增高特别明显而有显著意义的化学成分。同一肿瘤可含有多种肿瘤标记物，而不同肿瘤或同种肿瘤的不同组织类型除有共同的标志物外，也可有不同的标志物。也即某一肿瘤的标志物对另一肿瘤来说不一定是标志物，而某一组织的正常产物对另一组织来源的肿瘤却可成为较好的肿瘤标志物。肿瘤标志物不仅可以用于肿瘤的诊断和鉴别，还可用于治疗效果的观察和预后的估计。在妇产科常用的肿瘤标记物包括蛋白质肿瘤标记物：甲胎蛋白(AFP)、癌胚抗原(CEA)、癌抗原CA125、CA153，鞘糖脂类肿瘤标记物CA199，激素类肿瘤标记物HCG等。
